Читать книгу Blood and Marrow Transplantation Long Term Management - Группа авторов - Страница 38

APBMT countries/regions are characterized by its diversity in terms of the activity of HCT, social infrastructure, regulation for medical care and research, and the age of HCT. Thirteen countries/regions started HCT prior to 2000, with Japan, Singapore, Taiwan, and the Republic of Korea starting in 1986 [43]. Bangladesh, Myanmar, Sri Lanka, and Nepal started HCT from 2014. Establishment and dissemination of HCT and improvement of short‐term survival outcomes tend to be listed as priority issues in countries with a short history of HCT. Several studies have been performed in countries or regions with a long HCT history, including studies to address incidence and risk factors or outcomes of long‐term complications such as secondary malignancies after HCT, or long‐term effects of HCT for recipients in terms of quality of life and returning to work challenges [44–53].